PAHC
Price
$23.93
Change
-$0.58 (-2.37%)
Updated
Jun 13 closing price
Capitalization
523.71M
74 days until earnings call
VTRS
Price
$8.92
Change
-$0.17 (-1.87%)
Updated
Jun 13 closing price
Capitalization
14.18B
54 days until earnings call
Interact to see
Advertisement

PAHC vs VTRS

Header iconPAHC vs VTRS Comparison
Open Charts PAHC vs VTRSBanner chart's image
Phibro Animal Health
Price$23.93
Change-$0.58 (-2.37%)
Volume$152.03K
Capitalization523.71M
Viatris
Price$8.92
Change-$0.17 (-1.87%)
Volume$9M
Capitalization14.18B
PAHC vs VTRS Comparison Chart
Loading...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PAHC vs. VTRS commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAHC is a Hold and VTRS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2025
Stock price -- (PAHC: $23.93 vs. VTRS: $8.92)
Brand notoriety: PAHC and VTRS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: PAHC: 64% vs. VTRS: 59%
Market capitalization -- PAHC: $523.71M vs. VTRS: $14.18B
PAHC [@Pharmaceuticals: Other] is valued at $523.71M. VTRS’s [@Pharmaceuticals: Other] market capitalization is $14.18B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PAHC’s FA Score shows that 1 FA rating(s) are green whileVTRS’s FA Score has 2 green FA rating(s).

  • PAHC’s FA Score: 1 green, 4 red.
  • VTRS’s FA Score: 2 green, 3 red.
According to our system of comparison, both PAHC and VTRS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PAHC’s TA Score shows that 4 TA indicator(s) are bullish while VTRS’s TA Score has 6 bullish TA indicator(s).

  • PAHC’s TA Score: 4 bullish, 6 bearish.
  • VTRS’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, VTRS is a better buy in the short-term than PAHC.

Price Growth

PAHC (@Pharmaceuticals: Other) experienced а -0.62% price change this week, while VTRS (@Pharmaceuticals: Other) price change was +2.41% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.40%. For the same industry, the average monthly price growth was +14.50%, and the average quarterly price growth was +66.97%.

Reported Earning Dates

PAHC is expected to report earnings on Aug 27, 2025.

VTRS is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.40% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTRS($14.2B) has a higher market cap than PAHC($524M). VTRS has higher P/E ratio than PAHC: VTRS (238.80) vs PAHC (34.11). PAHC YTD gains are higher at: 15.091 vs. VTRS (-26.412). VTRS has higher annual earnings (EBITDA): 3.52B vs. PAHC (83.7M). VTRS has more cash in the bank: 1.18B vs. PAHC (92.5M). PAHC has less debt than VTRS: PAHC (513M) vs VTRS (18.4B). VTRS has higher revenues than PAHC: VTRS (15.4B) vs PAHC (982M).
PAHCVTRSPAHC / VTRS
Capitalization524M14.2B4%
EBITDA83.7M3.52B2%
Gain YTD15.091-26.412-57%
P/E Ratio34.11238.8014%
Revenue982M15.4B6%
Total Cash92.5M1.18B8%
Total Debt513M18.4B3%
FUNDAMENTALS RATINGS
PAHC vs VTRS: Fundamental Ratings
PAHC
VTRS
OUTLOOK RATING
1..100
2063
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
12
Undervalued
PROFIT vs RISK RATING
1..100
83100
SMR RATING
1..100
6294
PRICE GROWTH RATING
1..100
4560
P/E GROWTH RATING
1..100
921
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTRS's Valuation (12) in the null industry is in the same range as PAHC (23) in the Pharmaceuticals Major industry. This means that VTRS’s stock grew similarly to PAHC’s over the last 12 months.

PAHC's Profit vs Risk Rating (83) in the Pharmaceuticals Major industry is in the same range as VTRS (100) in the null industry. This means that PAHC’s stock grew similarly to VTRS’s over the last 12 months.

PAHC's SMR Rating (62) in the Pharmaceuticals Major industry is in the same range as VTRS (94) in the null industry. This means that PAHC’s stock grew similarly to VTRS’s over the last 12 months.

PAHC's Price Growth Rating (45) in the Pharmaceuticals Major industry is in the same range as VTRS (60) in the null industry. This means that PAHC’s stock grew similarly to VTRS’s over the last 12 months.

VTRS's P/E Growth Rating (1) in the null industry is significantly better than the same rating for PAHC (92) in the Pharmaceuticals Major industry. This means that VTRS’s stock grew significantly faster than PAHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PAHCVTRS
RSI
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 4 days ago
72%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
58%
Momentum
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
59%
MACD
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
61%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
60%
Advances
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 5 days ago
67%
Declines
ODDS (%)
Bearish Trend 24 days ago
72%
N/A
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
61%
Bearish Trend 2 days ago
70%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
47%
View a ticker or compare two or three
Interact to see
Advertisement
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AUERX14.02-0.03
-0.21%
Auer Growth
HBLIX14.61-0.08
-0.54%
Hartford Balanced Income I
SSDSX33.47-0.46
-1.36%
DWS Small Cap Growth S
MWEGX38.45-0.64
-1.64%
MFS Global Equity R1
TGRGX7.25-0.13
-1.76%
Transamerica International Focus I

PAHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, PAHC has been loosely correlated with PBH. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if PAHC jumps, then PBH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAHC
1D Price
Change %
PAHC100%
-2.37%
PBH - PAHC
48%
Loosely correlated
-1.37%
ZTS - PAHC
40%
Loosely correlated
-2.66%
ASRT - PAHC
39%
Loosely correlated
+2.43%
VTRS - PAHC
37%
Loosely correlated
-1.87%
ELAN - PAHC
37%
Loosely correlated
-2.54%
More

VTRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTRS has been loosely correlated with ZTS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if VTRS jumps, then ZTS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTRS
1D Price
Change %
VTRS100%
-1.87%
ZTS - VTRS
44%
Loosely correlated
-2.66%
AMRX - VTRS
42%
Loosely correlated
-2.64%
ELAN - VTRS
41%
Loosely correlated
-2.54%
PAHC - VTRS
39%
Loosely correlated
-2.37%
PBH - VTRS
37%
Loosely correlated
-1.37%
More